Menu

Image of the Day: Gnashers

A mollusk grows magnetic teeth so tough they can grind down rocks.  

Feb 18, 2019
Carolyn Wilke

ABOVE: Rows of gumboot chiton teeth embedded in a ribbonlike structure  
KISAILUS BIOMIMETICS & NANOMATERIALS LAB

The gumboot chiton, a type of mollusk, scrapes algae off rocks with its super tough teeth containing the magnetic mineral magnetite, a type of iron oxide. Fully mineralized chiton teeth are the hardest of all known biominerals and are strong enough to grind down rocks. 

So far, scientists only know of a few animals that make magnetite and how they do so is not well understood. To gather clues on how the mollusk deposits the mineral in the cusps of its teeth, researchers studied the transcriptome of their developing teeth. The 20 most prevalent RNA transcripts encoded ferritin, a protein that helps store iron and release it when needed, they reported January 29 in Scientific Reports.

The scientists then surveyed the proteins that were produced in the mineralized cusp and identified 22 specific to that area, including a previously unknown protein that the researchers think may help start the formation of the iron oxide. 

M. Nemoto et al., “Integrated transcriptomic and proteomic analyses of a molecular mechanism of radular teeth biomineralization in Cryptochiton stelleri,” Scientific Reports, doi: 10.1038/s41598-018-37839-2, 2019.

Chiton tooth with magnetite cusp
KISAILUS BIOMIMETICS & NANOMATERIALS LAB







UNIVERSITY OF CALIFORNIA, RIVERSIDE

March 2019

Going Under

Dissecting the effects of anesthetics

Marketplace

Sponsored Product Updates

The Complex Biology of Macrophages: Origins, Functions, and Activation States
The Complex Biology of Macrophages: Origins, Functions, and Activation States
Download this poster from R&D Systems for a detailed overview of macrophage markers, functions, development, specialization, and activation!
A Guide to Measuring Drug-Target Residence Times with Biochemical Assays
A Guide to Measuring Drug-Target Residence Times with Biochemical Assays
Download this guide from BellBrook Labs to learn about how to use Transcreener® biochemical assays to measure drug-target residence times, complete with examples and case studies!
Beckman Coulter Life Sciences To Launch New Product Via Live Stream Event
Beckman Coulter Life Sciences To Launch New Product Via Live Stream Event
After visiting labs around the world to identify ways to advance its industry-leading cell counting technology, Beckman Coulter Life Sciences will host a live streaming event on March 26 at 10 a.m. EDT / 7 a.m. PDT to announce its latest product innovation.  
Cybrexa Therapeutics to Present First Data and Unveil Details for its alphalex™-PARP Inhibitor Lead Candidate CBX-11 at AACR Annual Meeting 2019
Cybrexa Therapeutics to Present First Data and Unveil Details for its alphalex™-PARP Inhibitor Lead Candidate CBX-11 at AACR Annual Meeting 2019
Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced that Vishwas Paralkar, PhD, Chief Scientific Officer of Cybrexa, will present the first set of preclinical data supporting its alphalex™-PARP inhibitor lead candidate, CBX-11, at the American Association for Cancer Research (AACR) Annual Meeting 2019, being held March 29 – April 3 in Atlanta, Georgia. At the meeting, the Company will unveil the FDA-approved poly ADP-ribose polymerase (PARP) inhibitor conjugated in CBX-11.